526953 Stock Overview
Engages in the pharmaceutical business in India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Venus Remedies Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹294.50 |
| 52 Week High | ₹429.60 |
| 52 Week Low | ₹280.00 |
| Beta | 1.06 |
| 11 Month Change | -14.75% |
| 3 Month Change | -14.31% |
| 1 Year Change | -19.06% |
| 33 Year Change | -36.19% |
| 5 Year Change | 1,208.89% |
| Change since IPO | 677.04% |
Recent News & Updates
Recent updates
Shareholder Returns
| 526953 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.9% | -3.1% | -3.4% |
| 1Y | -19.1% | 41.1% | 27.0% |
Return vs Industry: 526953 underperformed the Indian Pharmaceuticals industry which returned 41.1% over the past year.
Return vs Market: 526953 underperformed the Indian Market which returned 27% over the past year.
Price Volatility
| 526953 volatility | |
|---|---|
| 526953 Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 526953 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 526953's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 1,187 | Ashutosh Jain | www.venusremedies.com |
Venus Remedies Limited engages in the pharmaceutical business in India and internationally. The company offers its products in various therapeutic areas, such as analgesic, analgesic and antipyretic, anti-diabetic, antibiotic, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormones, immunostimulating agent, iron supplements, muscle relaxant, neurology, oncology, solvent, respiratory, and anticoagulant. It is also involved in the provision of portfolio of herbal products.
Venus Remedies Limited Fundamentals Summary
| 526953 fundamental statistics | |
|---|---|
| Market cap | ₹3.94b |
| Earnings (TTM) | ₹221.11m |
| Revenue (TTM) | ₹6.15b |
17.8x
P/E Ratio0.6x
P/S RatioIs 526953 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 526953 income statement (TTM) | |
|---|---|
| Revenue | ₹6.15b |
| Cost of Revenue | ₹3.76b |
| Gross Profit | ₹2.38b |
| Other Expenses | ₹2.16b |
| Earnings | ₹221.11m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 14, 2025
| Earnings per share (EPS) | 16.54 |
| Gross Margin | 38.79% |
| Net Profit Margin | 3.60% |
| Debt/Equity Ratio | 8.3% |
How did 526953 perform over the long term?
See historical performance and comparison